联合消融的综合疗法在进展期胰腺癌中的现状与进展
DOI:
作者:
作者单位:

南京医科大学第二附属医院胰腺中心

作者简介:

通讯作者:

中图分类号:

基金项目:

南京市卫生科技发展专项资金项目一般性课题(YKK18188)


CurrentSstatus and progress of ablation-oriented combined treatment for advanced pancreatic cancer
Author:
Affiliation:

Pancreas Center,the 2nd Affiliated Hospital of Nanjing Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    进展期胰腺癌预后极差,恶性程度高,生存时间极短,难以靠外科手段来达到根治目的。单纯的放、化疗在进展期胰腺癌效果有限,患者总体生存时间并不理想,因此探索进展期胰腺癌的消融治疗一直是近些年来的研究热点,其中包含了射频消融术(RFA)、冷冻消融术(cryoablation)、不可逆电穿孔(IRE)、高强度聚焦超声治疗(HIFU)等诸多方式。不仅如此,消融联合放化疗以及免疫治疗等方案形成对进展期胰腺癌患者综合治疗策略,往往可以达到有效提高患者生存期的目的。本文对进展期胰腺癌中以消融为主体的综合整体治疗现况及进度作一综述。

    Abstract:

    Advanced pancreatic cancer has a poor prognosis and a short survival, and is usually can not treated by surgery.The efficacy of radiotherapy and chemotherapy alone in advanced pancreatic cancer is limited, and the overall survival time of patients is poor.Therefore, the exploration of ablation therapy for advanced pancreatic cancer has been a research hot spot in recent years.These include radio-frequency ablation (RFA), cryoablation, irreversible electroporation (IRE), high intensity focused ultrasound (HIFU) and many other methods.Moreover, ablation combined with chemoradiotherapy and immunotherapy can form a comprehensive treatment strategy for patients with advanced pancreatic cancer, often achieving the purpose of effectively improving the survival of patients.This article reviews the current status of comprehensive treatment strategies for advanced pancreatic cancer after ablation therapy.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-07-20
  • 最后修改日期:2021-11-18
  • 录用日期:2022-03-11
  • 在线发布日期:
  • 出版日期: